Sign in to continue:

Tuesday, February 17th, 2026

Wilmar International’s Electrifying Turnaround: Analyst Upgrades Amid Strategic Expansion and Soaring Margins

A seismic shift is on the horizon for Wilmar International as its latest strategic moves promise to supercharge profitability in 2025 and 2026. Aletheia Capital’s Nirgunan Tiruchelvam has thrown his weight behind the stock, raising revenue and earnings forecasts with enthusiasm. The catalyst? A high-potential acquisition and a revitalized soybean processing business in China, poised to overcome years of oversupply challenges and set the stage for impressive gains.

Market Buzz and a Bright Future

Despite a slight dip of 0.33% to S$3.03 on January 10, investor sentiment is poised for a turnaround. Wilmar’s robust dividend yield of 5.5%, combined with anticipated revenue growth, is generating a buzz among both retail and institutional investors. This dynamic blend of value and momentum is attracting renewed interest and setting the stage for a potential rally.

Undervalued Treasure Trove

Wilmar is sitting on a gold mine that the market has yet to fully appreciate. With a near-90% stake in its separately listed Chinese subsidiary, Yihai Kerry Arawana Holdings Co.—a company valued at a staggering $30 billion—Wilmar’s own market capitalization languishes below $20 billion. This discrepancy highlights an underappreciation of its broader asset portfolio, including its enhanced stake in Adani Wilmar, currently valued at $1.76 billion based on a 44% ownership prior to the new acquisition.

Wilmar International’s Turnaround: Analyst Upgrades Stock Amid Strategic Expansion and Rising Margin

On the technical side, the outlook is equally exciting. With a short-term target already set at $3.16, the potential to surge to $3.30 in the coming months signals an enticing upside of over 6%.

 

Wilmar International’s Turnaround: Analyst Upgrades Stock Amid Strategic Expansion and Rising Margin

 

Thank you

Venture Corporation: Possibly Another Year of Net Profit Decline Amid Trade War Escalation

Venture Corporation: Weathering the Trade War Storm CGS International | April 8, 2025 The tech manufacturing landscape has been rocked by the escalating trade tensions between the US and China, and Venture Corporation finds...

Sunshine Lake Pharma Co., Ltd. (06887.HK) – IPO Investor Fact Sheet

Sunshine Lake Pharma Co., Ltd. (06887.HK) – IPO Investor Fact Sheet (Main Board, Hong Kong Stock Exchange – Expected Listing: June 2025) IPO Snapshot Ticker: 06887.HK Market: Main Board, HKEX Expected Pricing: 10 June...

Samudera Shipping Line Ltd Bullish Outlook: Technical Buy, Target Prices & Market Analysis – August 2025 Singapore Retail Research

CGS International August 22, 2025 Bullish Momentum in Singapore Equities: Samudera Shipping and Pop Mart Lead Market Trends Market Overview: US Labor Market Weakens as Singapore Equities Show Technical Strength The latest market movements...

   Ad